← Open Payments lookup

MEREDITH SLAYTER: Open Payments

NPI 1932468428 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,094 in 98 payments from 18 companies in 2025. Trend: 2023 $1,967 · 2024 $1,915 · 2025 $2,094

Food & beverage: $2,060Education: $34
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$245
GlaxoSmithKline, LLC.13$213
GENZYME CORPORATION9$191
Verona Pharma, Inc.8$171
Takeda Pharmaceuticals U.S.A., Inc.8$161
Amgen Inc.7$157
Insmed, Inc.7$128
Regeneron Healthcare Solutions, Inc.5$126
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$124
Grifols USA, LLC5$99

Products named: DUPIXENT, TEZSPIRE, Ohtuvayre, GLASSIA, NUCALA, Arikayce, XIFAXAN, Prolastin-C Liquid.

Industry payments across IN — which companies pay providers there.